High-Dose Vitamin D May Slow Progression of MS-Like Neurological Disorder
By George Citroner A new clinical trial has found that high doses of vitamin D may significantly slow the progression of a neurological disorder known as clinically isolated syndrome (CIS). It is a condition that may look like multiple sclerosis (MS) and may precede MS. Both MS and CIS are caused by inflammation and damage to the central nervous system, specifically the brain and spinal…
More Stories
Analysts Set Expectations for CrowdStrike FY2026 Earnings
CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) – Research analysts at DA Davidson upped their FY2026 earnings per share (EPS)...
William Blair Has Bullish Estimate for CBIZ Q1 Earnings
CBIZ, Inc. (NYSE:CBZ – Free Report) – Stock analysts at William Blair lifted their Q1 2026 EPS estimates for CBIZ...
What is DA Davidson’s Forecast for CrowdStrike Q2 Earnings?
CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) – Analysts at DA Davidson issued their Q2 2026 earnings per share (EPS)...
Equities Analysts Offer Predictions for AMAT Q4 Earnings
Applied Materials, Inc. (NASDAQ:AMAT – Free Report) – Equities research analysts at Zacks Research lowered their Q4 2025 EPS estimates...
Zacks Research Issues Optimistic Estimate for LOW Earnings
Lowe’s Companies, Inc. (NYSE:LOW – Free Report) – Equities researchers at Zacks Research increased their Q2 2026 earnings estimates for...
Zacks Research Issues Negative Estimate for Neogen Earnings
Neogen Co. (NASDAQ:NEOG – Free Report) – Stock analysts at Zacks Research decreased their FY2026 earnings per share (EPS) estimates...